Stem
STEM
NYSE
IPO2021
about STEM
Stem specializes in developing cutting-edge stem cell-based therapies and innovative solutions aimed at advancing medical treatments in regenerative medicine.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $14.98 | $15.35 | $14.77 | $124.14M | 71.47K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$24.31 | n/a | 3.29 | -34.77% | 527.78% | 0% |
